Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis

This study has been suspended.

( Further evaluation of pharmacokinetic data in the target population is ongoing )

Study NCT00815516 Information provided by Astellas Pharma Inc

First Received: December 27, 2008 Last Updated: December 7, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been suspended.
Estimated Study Completion Date:	August 2013
Estimated Primary Completion Date:	August 2013 (Final data collection date for primary outcome measure)